In the Q1 2025 financial report, IVS announced revenues of 100 million USD, a 15% increase compared to the same period last year. Net profit reached 20 million USD, corresponding to a net profit margin of 20%. The company attributed revenue growth mainly to market expansion and new product development. Notably, operating expenses increased by 10% due to higher investments in R&D and marketing. IVS’s total assets at the end of Q1 2025 reached 500 million USD, while total liabilities stood at 200 million USD, indicating stable financial capacity. IVS also announced growth plans for the next quarter, aiming for revenues of 120 million USD, capitalizing on market transformation opportunities. The company continues to improve production processes to reduce costs. Optimism about business prospects is reflected in its stable dividend policy, planning a 5% dividend payout for shareholders in the upcoming period.
Leave a Reply